| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | $44.4M+96.6% | $22.6M-17.2% | $27.2M+24.3% | $21.9M-35.7% | $34.1M-12.2% | $38.8M-0.4% | $39.0M+11.4% | $35.0M+50.0% | $23.3M |
| Cost of product revenue | $9.3M-42.7% | $16.3M+27.2% | $12.8M-66.3% | $38.0M+71.3% | $22.2M+61.6% | $13.7M-12.1% | $15.6M+23.9% | $12.6M-11.9% | $14.3M |
| Research and development | $52.3M+13.1% | $46.3M-21.4% | $58.9M-26.5% | $80.1M+43.2% | $55.9M+26.6% | $44.2M+30.4% | $33.9M+13.0% | $30.0M+1.1% | $29.7M |
| Selling, general and administrative | $47.1M-14.6% | $55.1M+3.6% | $53.3M+2.1% | $52.2M+5.8% | $49.3M+40.7% | $35.0M+11.3% | $31.5M+7.5% | $29.3M+1.0% | $29.0M |
| Restructuring charges | $3.4M | $0-100.0% | $3.3M+3.7% | $3.2M | $0 | $0 | — | — | — |
| Asset impairment and other charges | $0-100.0% | $165K-98.3% | $10.0M | $0 | $0 | — | — | — | — |
| Total costs and operating expenses | $112.1M-4.9% | $117.9M-14.7% | $138.2M-20.3% | $173.5M+36.1% | $127.5M+37.1% | $93.0M+14.8% | $81.0M+12.7% | $71.9M-1.5% | $73.0M |
| Loss from operations | -$41.7M+28.7% | -$58.5M+14.0% | -$68.1M-95.1% | -$34.9M-53.7% | -$22.7M+5.1% | -$23.9M-90.6% | -$12.5M-11.1% | -$11.3M+50.8% | -$23.0M |
| Interest income | $2.6M-28.5% | $3.7M-12.0% | $4.2M+189.5% | $1.4M+213.9% | $459K+13.3% | $405K-68.5% | $1.3M+91.8% | $671K+356.5% | $147K |
| Interest and other expense, net | -$4.8M+53.7% | -$10.4M+15.3% | -$12.3M-9998.4% | $124K-89.2% | $1.1M+835.9% | -$156K+76.2% | -$656K-125.4% | -$291K-216.3% | -$92K |
| Loss before income taxes | -$43.9M+32.7% | -$65.2M+14.3% | -$76.2M-128.6% | -$33.3M-58.0% | -$21.1M+10.9% | -$23.7M-98.6% | -$11.9M-9.2% | -$10.9M+52.4% | -$22.9M |
| Provision for income taxes | $47K+38.2% | $34K-50.7% | $69K-75.0% | $276K+46.0% | $189K-44.2% | $339K+1894.1% | $17K+145.9% | -$37K-145.7% | $81K |
| Net loss | -$44.0M+32.6% | -$65.3M+14.4% | -$76.2M-127.0% | -$33.6M-57.9% | -$21.3M+11.4% | -$24.0M-101.2% | -$11.9M-9.7% | -$10.9M+52.7% | -$23.0M |
| Net loss per share, basic (in dollars per share) | -$500.00+43.8% | -$890.00+20.5% | -$1120.00-119.6% | -$510.00-54.5% | -$330.00+17.5% | -$400.00-190376.2% | -$0.21 | — | — |
| Net loss per share, diluted (in dollars per share) | -$500.00+43.8% | -$890.00+20.5% | -$1120.00-119.6% | -$510.00-54.5% | -$330.00+17.5% | -$400.00-190376.2% | -$0.21 | — | — |
| Weighted average common stock shares used in computing net loss per share, basic (in shares) | $87142000.00+18.7% | $73408000.00+7.7% | $68131000.00+4.3% | $65344000.00+1.2% | $64568000.00+8.8% | $59360000.00+104915.5% | $56525.00 | — | — |
| Weighted average common stock shares used in computing net loss per share, diluted (in shares) | $87142000.00+18.7% | $73408000.00+7.7% | $68131000.00+4.3% | $65344000.00+1.2% | $64568000.00+8.8% | $59360000.00+104915.5% | $56525.00 | — | — |
| Product revenue | |||||||||
| Research and development revenue | |||||||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.